MedEffect Canada
Features
MedEffect Canada provides consumers, patients, and health professionals with easy access to:
- Report an adverse reaction or side effect;
- Obtain new safety information on drugs and other health products; and
- Learn and better understand the importance of reporting side effects.
Latest Advisories and Recalls
Search for advisories and recalls in the Recalls and Safety Alerts Database
What's New
- Monthly Update to the Canada Vigilance adverse reaction online database [2020-07-03]
- Picato (ingenol mebutate) – Assessing the Potential Risk of Skin Cancer [2020-07-02]
- Monthly Update to the List of New Safety and Effectiveness Reviews [2020-07-02]
- Health Product InfoWatch, June 2020 [2020-06-25]
- Xeljanz and Xeljanz XR (tofacitinib) and Jakavi (ruxolitinib) - Janus Kinase (JAK) inhibitors - Assessing the Potential Risk of Blood Clots in the Deep Veins (Venous Thromboembolic Events) [2020-06-18]
Related Resources
Report a problem or mistake on this page
- Date modified: